Staphylococcus aureus (MRSA) Reduction
- Authors
-
Travis R. Farley, Study Director
- Facility
-
Microbac Laboratories, Inc.; North Carolina
- Download
- Full Report
Objective
To evaluate the efficacy of the Protect 900 (Nano +) on reducing methicillin-resistant Staphylococcus aureus (MRSA).
Methodology
The challenge bacteria were aerosolized using a six-jet collision nebulizer under high pressure air and introduced into the chamber with the Protect 900 (Nano +).
Summary of Results
The Protect 900 (Nano +) reduced 99.99% of Staphylococcus aureus bacteria over the course of four hours.
CONTACT US
USA Headquarters
Stamford, Connecticut
Call: 1 866 508 1118 Email: info@wellairsolutions.com
Ireland Headquarters
DCU Innovation Campus Old Finglas Road Glasnevin, Dublin 11
Call: +353 1 907 2750 Email: info@wellairsolutions.com